James E Flynn - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made 1 insider transaction in Larimar Therapeutics Inc (LRMR) with a net purchase of 4,290,617. Other recent insider transactions involving Larimar Therapeutics Inc (LRMR) include a net purchase of 57,208 shares made by Thomas Edward Hamilton , a net purchase of 2,000 shares made by Frank E Thomas ,

In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc (LRMR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc (LRMR) were sold and 4,349,825 shares were bought by its insiders, resulting in a net purchase of 4,349,825 shares.

Larimar Therapeutics Inc (LRMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 91,933 shares made by Eric W Roberts , a net purchase of 167,054 shares made by Robert N Wilson , and a net purchase of 791,928 shares made by Fred A Middleton .

In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 22,600 shares, with a net purchase of 22,600 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,842,043 shares were bought by its insiders, resulting in a net purchase of 1,842,043 shares.

CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Acutus Medical Inc (AFIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acutus Medical Inc (AFIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acutus Medical Inc (AFIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 42,056 shares made by Ted Yednock , a net purchase of 29,715 shares made by William H. Carson , and a net sale of 14,204 shares made by Jennifer Lew .

In summary, during the past 3 months, insiders sold 0 shares of Annexon Inc (ANNX) in total and bought 4,115 shares, with a net purchase of 4,115 shares. During the past 18 months, 90,226 shares of Annexon Inc (ANNX) were sold and 29,715 shares were bought by its insiders, resulting in a net sale of 60,511 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Deerfield Healthcare Technology Acquisitions Corp (DFHTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Deerfield Healthcare Technology Acquisitions Corp (DFHTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 30,635 shares made by Paul J Hastings , a net sale of 18,261 shares made by Alicia J. Hager , and a net sale of 12,646 shares made by David Shook .

In summary, during the past 3 months, insiders sold 1,790 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 1,790 shares. During the past 18 months, 86,727 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,913,273 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net purchase of 210,791 shares made by Anthony G. Quinn , and a net sale of 6,719 shares made by Antoinette Paone .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,719 shares of Generation Bio Co (GBIO) were sold and 210,791 shares were bought by its insiders, resulting in a net purchase of 204,072 shares.

Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DFP Healthcare Acquisitions Corp (DFPHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DFP Healthcare Acquisitions Corp (DFPHU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 39,210 shares made by Jeff Cislini , a net sale of 246,401 shares made by Mark A Goldsmith , and a net sale of 125,720 shares made by Stephen Michael Kelsey .

In summary, during the past 3 months, insiders sold 29,428 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 29,428 shares. During the past 18 months, 561,898 shares of Revolution Medicines Inc (RVMD) were sold and 1,304,347 shares were bought by its insiders, resulting in a net purchase of 742,449 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Schrodinger Inc (SDGR). Other recent insider transactions involving Schrodinger Inc (SDGR) include a net sale of 2,312 shares made by Jenny Herman , a net sale of 8,806 shares made by Geoffrey Craig Porges , and a net sale of 2,430 shares made by Robert Lorne Abel .

In summary, during the past 3 months, insiders sold 16,723 shares of Schrodinger Inc (SDGR) in total and bought 0 shares, with a net sale of 16,723 shares. During the past 18 months, 35,274 shares of Schrodinger Inc (SDGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,274 shares.

Schrodinger Inc (SDGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net sale of 5,784,292 shares made by Biotech Growth N V , and a net sale of 221,600 shares made by Versant Venture Capital Vi, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,005,892 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,005,892 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 13,037 shares made by Arthur Tzianabos , a net sale of 7,280 shares made by Paul Alloway , and a net sale of 1,708 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,224 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,224 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AdaptHealth Corp (DFBHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AdaptHealth Corp (DFBHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AdaptHealth Corp (DFBHU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Cabaletta Bio Inc (CABA). Other recent insider transactions involving Cabaletta Bio Inc (CABA) include a net sale of 11,000 shares made by Gwendolyn Binder ,

In summary, during the past 3 months, insiders sold 0 shares of Cabaletta Bio Inc (CABA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,000 shares of Cabaletta Bio Inc (CABA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,000 shares.

Cabaletta Bio Inc (CABA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc (FREQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frequency Therapeutics Inc (FREQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Frequency Therapeutics Inc (FREQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 66,875 shares made by Jolanda Howe , a net sale of 38,032 shares made by Peter Radovich , and a net sale of 101,929 shares made by Christopher Peetz .

In summary, during the past 3 months, insiders sold 11,406 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 0 shares, with a net sale of 11,406 shares. During the past 18 months, 265,258 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 10,709 shares were bought by its insiders, resulting in a net sale of 254,549 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , and a net purchase of 666,666 shares made by Anand Mehra .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aclaris Therapeutics Inc (ACRS) were sold and 5,520,718 shares were bought by its insiders, resulting in a net purchase of 5,520,718 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Shockwave Medical Inc (SWAV). Other recent insider transactions involving Shockwave Medical Inc (SWAV) include a net sale of 30,000 shares made by Douglas Evan Godshall , a net sale of 12,000 shares made by Isaac Zacharias , and a net sale of 6,000 shares made by Frank T Watkins .

In summary, during the past 3 months, insiders sold 0 shares of Shockwave Medical Inc (SWAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 119,042 shares of Shockwave Medical Inc (SWAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 119,042 shares.

Shockwave Medical Inc (SWAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 18,700 shares made by John P. Schmid , a net sale of 40,000 shares made by Beth Hecht , and a net purchase of 25,000 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 40,000 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 43,700 shares were bought by its insiders, resulting in a net purchase of 3,700 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Arvinas Inc (ARVN). Other recent insider transactions involving Arvinas Inc (ARVN) include a net sale of 36,534 shares made by John G Houston , a net sale of 10,721 shares made by Ian Taylor , and a net sale of 8,658 shares made by .

In summary, during the past 3 months, insiders sold 8,283 shares of Arvinas Inc (ARVN) in total and bought 0 shares, with a net sale of 8,283 shares. During the past 18 months, 73,478 shares of Arvinas Inc (ARVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 73,478 shares.

Arvinas Inc (ARVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,300 shares made by Thomas S Mchugh , a net purchase of 8,000 shares made by Linda Palczuk , and a net purchase of 30,000 shares made by Eric J Ende .

In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 87,579 shares were bought by its insiders, resulting in a net purchase of 87,579 shares.

Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Protara Therapeutics Inc (TARA). Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net sale of 703,460 shares made by Opaleye Management Inc. , a net purchase of 40,000 shares made by Richard S Levy , and a net sale of 21,224 shares made by Jacqueline Zummo .

In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 40,000 shares, with a net purchase of 40,000 shares. During the past 18 months, 724,684 shares of Protara Therapeutics Inc (TARA) were sold and 40,000 shares were bought by its insiders, resulting in a net sale of 684,684 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 244,593 shares made by Eben Tessari , a net sale of 408,607 shares made by Sanj K Patel , and a net sale of 246,546 shares made by Mark Ragosa .

In summary, during the past 3 months, insiders sold 522,197 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 522,197 shares. During the past 18 months, 1,297,332 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,297,332 shares.

Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MNKKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MNKKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mallinckrodt PLC (MNKKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 121,639 shares made by Pamela J. Cramer , a net sale of 147,884 shares made by Joseph Shulman , and a net sale of 118,525 shares made by Jennifer Chien .

In summary, during the past 3 months, insiders sold 193,837 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 193,837 shares. During the past 18 months, 849,479 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 849,479 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Societal CDMO Inc (SCTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Societal CDMO Inc (SCTL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Societal CDMO Inc (SCTL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in eHealth Inc (EHTH). Other recent insider transactions involving eHealth Inc (EHTH) include a net purchase of 26,865 shares made by Gavin G. Galimi , a net purchase of 50,000 shares made by Soistman Francis S Jr , and a net purchase of 20,000 shares made by John J Stelben .

In summary, during the past 3 months, insiders sold 0 shares of eHealth Inc (EHTH) in total and bought 9,500 shares, with a net purchase of 9,500 shares. During the past 18 months, 20,000 shares of eHealth Inc (EHTH) were sold and 96,865 shares were bought by its insiders, resulting in a net purchase of 76,865 shares.

eHealth Inc (EHTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of CAS Medical Systems Inc (CASM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CAS Medical Systems Inc (CASM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CAS Medical Systems Inc (CASM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Invuity Inc (IVTY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invuity Inc (IVTY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Invuity Inc (IVTY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net purchase of 34,828 shares made by Mihael Hristos Polymeropoulos , a net sale of 14,951 shares made by Kevin Patrick Moran , and a net sale of 12,000 shares made by Stephen Ray Mitchell .

In summary, during the past 3 months, insiders sold 7,000 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 30,000 shares, with a net purchase of 23,000 shares. During the past 18 months, 135,349 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 92,000 shares were bought by its insiders, resulting in a net sale of 43,349 shares.

Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 118,000 shares made by James Paul Rickey , and a net sale of 19 shares made by James N Topper .

In summary, during the past 3 months, insiders sold 0 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 118,019 shares of Alpine Immune Sciences Inc (ALPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 118,019 shares.

Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Axogen Inc (AXGN). Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 49,518 shares made by Joseph A. Tyndall , a net sale of 42,343 shares made by Michael Patrick Donovan , and a net sale of 19,689 shares made by Erick Wayne Devinney .

In summary, during the past 3 months, insiders sold 73,956 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 73,956 shares. During the past 18 months, 212,149 shares of Axogen Inc (AXGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 212,149 shares.

Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 22,700 shares made by David Roth , a net sale of 171,783 shares made by Nancy A Simonian , and a net sale of 37,803 shares made by Jason Haas .

In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 549,873 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 200,000 shares were bought by its insiders, resulting in a net sale of 349,873 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XenoPort Inc (XNPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XenoPort Inc (XNPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XenoPort Inc (XNPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AveXis Inc (AVXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AveXis Inc (AVXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AveXis Inc (AVXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 125,012 shares made by Gilmore Neil O'neill , a net sale of 28,516 shares made by Baisong Mei , and a net sale of 15,503 shares made by Linda Burkly .

In summary, during the past 3 months, insiders sold 16,364 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 16,364 shares. During the past 18 months, 195,923 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 150,923 shares.

Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Streamline Health Solutions Inc (STRM). Other recent insider transactions involving Streamline Health Solutions Inc (STRM) include a net purchase of 6,300 shares made by Benjamin Louis Stilwill ,

In summary, during the past 3 months, insiders sold 0 shares of Streamline Health Solutions Inc (STRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Streamline Health Solutions Inc (STRM) were sold and 420 shares were bought by its insiders, resulting in a net purchase of 420 shares.

Streamline Health Solutions Inc (STRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alimera Sciences Inc (ALIM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 127,288 shares made by Sean A. Mccarthy , a net sale of 50,372 shares made by Marcia Belvin , and a net sale of 25,761 shares made by Christopher Ogden .

In summary, during the past 3 months, insiders sold 81,650 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 81,650 shares. During the past 18 months, 237,841 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 237,841 shares.

CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 155,602 shares made by Kenneth T. Mills , a net sale of 51,100 shares made by Argeris N Karabelas , and a net sale of 9,748 shares made by Curran Simpson .

In summary, during the past 3 months, insiders sold 20,602 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 20,602 shares. During the past 18 months, 229,328 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 229,328 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 2,156 shares made by Jill Marie Broadfoot , a net purchase of 4,101 shares made by Nancy Krueger , and a net purchase of 100,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,743 shares of aTyr Pharma Inc (ATYR) were sold and 183,750 shares were bought by its insiders, resulting in a net purchase of 180,007 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of SteadyMed Ltd (STDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SteadyMed Ltd (STDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SteadyMed Ltd (STDY)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Invitae Corp (NVTAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Invitae Corp (NVTAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Invitae Corp (NVTAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 1,235,943 shares made by Braden Michael Leonard , a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , and a net purchase of 100,000 shares made by James Paul Scopa .

In summary, during the past 3 months, insiders sold 13,010 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 350,000 shares, with a net purchase of 336,990 shares. During the past 18 months, 13,010 shares of Adverum Biotechnologies Inc (ADVM) were sold and 1,258,943 shares were bought by its insiders, resulting in a net purchase of 1,245,933 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NxStage Medical Inc (NXTM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NxStage Medical Inc (NXTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NxStage Medical Inc (NXTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 62,246 shares made by Raul R Rodriguez , a net sale of 18,440 shares made by David A Santos , and a net sale of 16,398 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 27,834 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 27,834 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of The Medicines Co (MDCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of The Medicines Co (MDCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

The Medicines Co (MDCO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in NeuroMetrix Inc (NURO). Other recent insider transactions involving NeuroMetrix Inc (NURO) include a net sale of 1,000 shares made by Joshua Horowitz ,

In summary, during the past 3 months, insiders sold 0 shares of NeuroMetrix Inc (NURO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000 shares of NeuroMetrix Inc (NURO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,000 shares.

NeuroMetrix Inc (NURO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Fibrocell Science Inc (FCSC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fibrocell Science Inc (FCSC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Fibrocell Science Inc (FCSC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net sale of 194,628,820 shares made by David E. Lazar ,

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,164,301 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,164,301 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 56,784 shares made by David F Novack , a net sale of 20,526 shares made by Justin Burgess , and a net sale of 3,615 shares made by Francis Cano .

In summary, during the past 3 months, insiders sold 0 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 82,425 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 82,425 shares.

Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of VIA Pharmaceuticals Inc (VIAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIA Pharmaceuticals Inc (VIAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

VIA Pharmaceuticals Inc (VIAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Edgewise Therapeutics Inc (EWTX). Other recent insider transactions involving Edgewise Therapeutics Inc (EWTX) include a net sale of 187,542 shares made by Alan J Russell , a net sale of 65,477 shares made by Behrad Derakhshan , and a net sale of 218,563 shares made by R Michael Carruthers .

In summary, during the past 3 months, insiders sold 15,949 shares of Edgewise Therapeutics Inc (EWTX) in total and bought 993,542 shares, with a net purchase of 977,593 shares. During the past 18 months, 664,029 shares of Edgewise Therapeutics Inc (EWTX) were sold and 1,902,632 shares were bought by its insiders, resulting in a net purchase of 1,238,603 shares.

Edgewise Therapeutics Inc (EWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made 1 insider transaction in AdaptHealth Corp (AHCO) with a net sale of 350,000. Other recent insider transactions involving AdaptHealth Corp (AHCO) include a net sale of 135,443 shares made by Albert A. Prast , a net sale of 35,000 shares made by Jason A Clemens , and a net sale of 25,000 shares made by Shaw Rietkerk .

In summary, during the past 3 months, insiders sold 0 shares of AdaptHealth Corp (AHCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 560,952 shares of AdaptHealth Corp (AHCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 560,952 shares.

AdaptHealth Corp (AHCO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Werewolf Therapeutics Inc (HOWL). Other recent insider transactions involving Werewolf Therapeutics Inc (HOWL) include a net purchase of 536,426 shares made by Ra Capital Healthcare Fund Lp , a net sale of 4,386 shares made by Mpm Oncology Innovations Fund Lp , and a net sale of 2,425 shares made by Luke Evnin .

In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 536,426 shares, with a net purchase of 536,426 shares. During the past 18 months, 8,774 shares of Werewolf Therapeutics Inc (HOWL) were sold and 536,426 shares were bought by its insiders, resulting in a net purchase of 527,652 shares.

Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in The Oncology Institute Inc (TOI). Other recent insider transactions involving The Oncology Institute Inc (TOI) include a net sale of 1,621,801 shares made by Brad Hively , a net sale of 80,000 shares made by Havencrest Healthcare Partners, L.p. , and a net sale of 2,750,000 shares made by M33 Growth I L.p. .

In summary, during the past 3 months, insiders sold 4,726,137 shares of The Oncology Institute Inc (TOI) in total and bought 0 shares, with a net sale of 4,726,137 shares. During the past 18 months, 4,806,137 shares of The Oncology Institute Inc (TOI) were sold and 1,889,378 shares were bought by its insiders, resulting in a net sale of 2,916,759 shares.

The Oncology Institute Inc (TOI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of CareMax Inc (CMAXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CareMax Inc (CMAXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CareMax Inc (CMAXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net sale of 62,000 shares made by Jill M. Quigley , a net purchase of 39,274 shares made by Amy L. Burroughs , and a net sale of 22,397 shares made by Mark J. Vignola .

In summary, during the past 3 months, insiders sold 0 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 48,314 shares, with a net purchase of 48,314 shares. During the past 18 months, 627,612 shares of Terns Pharmaceuticals Inc (TERN) were sold and 552,296 shares were bought by its insiders, resulting in a net sale of 75,316 shares.

Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNYU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNYU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNYU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in PepGen Inc (PEPG). Other recent insider transactions involving PepGen Inc (PEPG) include a net sale of 50,000 shares made by Michelle L Mellion , a net purchase of 51,500 shares made by James G Mcarthur , and a net purchase of 2,557,593 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of PepGen Inc (PEPG) in total and bought 59,875 shares, with a net purchase of 59,875 shares. During the past 18 months, 62,959 shares of PepGen Inc (PEPG) were sold and 2,617,468 shares were bought by its insiders, resulting in a net purchase of 2,554,509 shares.

PepGen Inc (PEPG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net purchase of 2,245,228 shares made by Gilead Sciences Inc , a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 70,000 shares made by James Samuel Shannon .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 106,289 shares, with a net purchase of 106,289 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 2,351,517 shares were bought by its insiders, resulting in a net purchase of 2,346,282 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made no insider transaction in Singular Genomics Systems Inc (OMIC). Other recent insider transactions involving Singular Genomics Systems Inc (OMIC) include a net sale of 1,850 shares made by Andrew Spaventa , and a net purchase of 122,416 shares made by Kevin C Tang .

In summary, during the past 3 months, insiders sold 0 shares of Singular Genomics Systems Inc (OMIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,850 shares of Singular Genomics Systems Inc (OMIC) were sold and 122,416 shares were bought by its insiders, resulting in a net purchase of 120,566 shares.

Singular Genomics Systems Inc (OMIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, James E Flynn made 1 insider transaction in Nuvalent Inc (NUVL) with a net sale of 2,000,000. Other recent insider transactions involving Nuvalent Inc (NUVL) include a net sale of 324,000 shares made by Matthew Shair , a net sale of 99,016 shares made by Darlene Noci , and a net sale of 72,964 shares made by Deborah Ann Miller .

In summary, during the past 3 months, insiders sold 124,000 shares of Nuvalent Inc (NUVL) in total and bought 0 shares, with a net sale of 124,000 shares. During the past 18 months, 5,067,758 shares of Nuvalent Inc (NUVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,067,758 shares.

Nuvalent Inc (NUVL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DA32 Life Science Tech Acquisition Corp (DALS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MCKPF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MCKPF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mallinckrodt PLC (MCKPF)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.